SCHEMBL7149982

SCHEMBL7149982

CC(C)n1c(Br)nc2c(Cl)ncnc21

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 12/20 0.67
ADORA1 P30542 12/20 0.67
ADORA2B P29275 11/20 0.67
ADORA3 P0DMS8 4/20 0.67
DAPK1 P53355 1/20 0.35
CCNA2 P20248 1/20 0.33
CDK2 P24941 1/20 0.33
CCNA1 P78396 1/20 0.33
CDK5 Q00535 1/20 0.33
DYRK1A Q13627 1/20 0.33
CDK5R1 Q15078 1/20 0.33
FDPS P14324 1/20 0.33
PI4KA P42356 1/20 0.33
PI4K2B Q8TCG2 1/20 0.33
PI4K2A Q9BTU6 1/20 0.33
PI4KB Q9UBF8 1/20 0.33
HSP90B1 P14625 1/20 0.32
FGFR1 P11362 1/20 0.32
FGFR4 P22455 1/20 0.32
ADK P55263 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL788330 0.77 ADORA2A (0.64) ADORA2AADORA1ADORA2BADORA3PI4KA
SCHEMBL31065821 0.77 ADORA2A (0.64) ADORA2AADORA1ADORA2BADORA3PI4KA
SCHEMBL31060376 0.76 ADORA2A (0.61) ADORA2AADORA1ADORA2BADORA3DAPK1
SCHEMBL4057715 0.74 ADORA3 (0.46) ADORA2AADORA1ADORA2BADORA3DAPK1
SCHEMBL29782848 0.72 ADORA2A (0.40) ADORA2AADORA1ADORA2BADORA3
SCHEMBL29782930 0.72 ADORA2A (0.39) ADORA2AADORA1ADORA2BADORA3
SCHEMBL30893381 0.69 MEN1 (0.41) ADORA2AADORA1ADORA2BADORA3ADK
SCHEMBL13773248 0.69 ADORA2A (0.60) ADORA2AADORA1ADORA2BADORA3CDK2
SCHEMBL7006036 0.68 ADORA2A (0.66) ADORA2AADORA1ADORA2BADORA3CDK2
SCHEMBL2475932 0.67 ADORA2A (0.64) ADORA2AADORA1ADORA2BCCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030187261-A1 Purine derivatives, process for their preparation and use thereof USTAV EXPERIMANTALNI BOTANIKY AKADEMIE VED CESKE REPUBLIKY (CZ) 2003-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187261-A1 Purine derivatives, process for their preparation and use thereof DCK, DTYMK, CCNK ADORA2A 383/4885ADORA1 1047/4885ADORA2B 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.